Project R-7115

NanoBit : Nanoscintillator-Porphyrin complexes for bimodal radiophotodynamic thearpy. (Research)

Cancer is a European and global problem. However, existing diagnostic and treatment modalities are not completely optimal. Radiotherapy is a leading choice for cancer treatment. However, radiotherapy has a series of adverse effects. While radiation is effective in eradicating tumour cells in many cases, damage to healthy issues and incomplete tumour response or radio resistance are considered to be major obstacles to the succes of radiotherapy. Radiation has to be delivered using complex technological means to induce cell deaths electively in diseased tissues. Numerous agents have been developed to enhance radiation effects. However, they have not been successful due to undetermined efficiency improvements in a patient response to radiotherapy.

01 January 2016 - 31 March 2019